Ediang, Mary Ann C.
HRN: 25-54-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2024
CEFTRIAXONE 1G (VIAL)
07/26/2024
08/02/2024
IV
2g
Q 24H
T/C UTI; R/O Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes